To investigate the relationship between RNF220 and the tumor immune microenvironment, we first employed the xCELL algorithm to analyze RNA-seq data from AML and ALL patients in the TCGA and TARGET cohorts, assessing correlations between RNF220 expression and immune cell subtype proportions. This evidence concerns the gene RNF220 and neoplasm.